Metraipolis › archive › dc_39b9852eedba

Real-world effectiveness and safety of imeglimin: a single-center retrospective cohort study in Japan — Europe PMC PMID:41476904

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41476904
DOI
10.3389/fcdhc.2025.1694522
License (as archived)
solo-consultazione
Archived
2026-11-07T14:39:49.917Z
SHA-256 of the archived text
44f841cbd64493eba25f7cbaa70e6108b9c05ad316d686238f6ba74733135223
Stable URL of this page
https://metraipolis.com/documento/dc_39b9852eedba

How to cite

Real-world effectiveness and safety of imeglimin: a single-center retrospective cohort study in Japan — Europe PMC PMID:41476904 — Europe PMC (en), https://europepmc.org/article/MED/41476904 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_39b9852eedba (Metraipolis archive dc_39b9852eedba, sha256 44f841cbd64493eba25f7cbaa70e6108b9c05ad316d686238f6ba74733135223)
BibTeX
@misc{dc39b9852eedba,
  title = {Real-world effectiveness and safety of imeglimin: a single-center retrospective cohort study in Japan — Europe PMC PMID:41476904},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476904},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_39b9852eedba; sha256 44f841cbd64493eba25f7cbaa70e6108b9c05ad316d686238f6ba74733135223},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476904. Agents can read the archived copy with the MCP tool read_document.